1 study found for:    NCT00817206
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Condition: Acute Allograft Rejection
Interventions: Drug: LCP-Tacro™ Tablets (tacrolimus);   Drug: Prograf® capsules (tacrolimus)

Indicates status has not been verified in more than two years